Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for manufacturing cell therapies. Scott R. Burger ...
Induced pluripotent stem cells (iPSCs) are a “starting material grail” for advanced therapies. That’s according to Sven Kili, chief development officer at CCRM, the Canadian regenerative medicine ...
100% starting materials identification testing is a requirement according to the US FDA’s directive 211.84 for FDA-regulated industries such as Vaccines, Tobacco, Pharmaceutical, Food, Cosmetics, ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE:CRL) today announced the launch of their new CliniPrime TM suite of Good Manufacturing Practice (GMP)-compliant ...
Brussels, 13 November 2025 – Researchers at the VIB-VUB Center for Structural Biology have developed a new microfluidics-based workflow that enables high-resolution cryogenic electron microscopy (cryo ...